![Daniel Veber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Daniel Veber
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Circle Pharma, Inc.
![]() Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA.
9
| Holding Company | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Veber
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The Column Group LLC
![]() The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Founder Private Equity Investor Director of Finance/CFO | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
ShangPharma Innovation, Inc.
![]() ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Investment Managers | Chief Executive Officer Consultant / Advisor | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Consultant / Advisor Founder | |
The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
GERON CORPORATION | Biotechnology | General Counsel Chief Tech/Sci/R&D Officer | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Stanford University | College/University | Undergraduate Degree | |
Glaxo, Inc. | Corporate Officer/Principal | ||
The University of Texas at Austin | College/University | Doctorate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VHL Alliance | Director/Board Member | ||
Nura Bio, Inc.
![]() Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Atavistik Bio, Inc.
![]() Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Biotechnology | Chairman | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The University of Colorado | College/University | Masters Business Admin | |
Colorado State University | College/University | Undergraduate Degree | |
The Graduate Group Ltd.
![]() The Graduate Group Ltd. Personnel ServicesCommercial Services Part of Reach Plc, The Graduate Group Ltd. is a British company that provides graduate recruitment services. The company is based in London, UK. Founded in 1999. | Personnel Services | Director/Board Member | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Onkaido Therapeutics LLC
![]() Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The company is based in Cambridge, MA. | Pharmaceuticals: Major | President | |
MEDIVATION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
University of Birmingham | College/University | Doctorate Degree | |
Purdue University | College/University | Undergraduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree | |
SCHRÖDINGER, INC. | Packaged Software | Corporate Officer/Principal | |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
RELAY THERAPEUTICS, INC. | Biotechnology | Founder | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Santa Clara University | College/University | Masters Business Admin | |
California Society of CPAs | Corporate Officer/Principal | ||
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fisher Asset Management LLC
![]() Fisher Asset Management LLC Investment ManagersFinance Fisher Asset Management LLC, dba Fisher Investments (FI), is a SEC-registered investment advisor headquartered in Plano, Texas. The firm was founded in 1979 by Ken Fisher and is a subsidiary of Fisher Investments, Inc. FI manages the assets of a diverse global client base which includes corporations, public and multi-employer pension funds, foundations and endowments, insurance companies, health-care organizations, governments and high net worth families. | Investment Managers | Private Equity Investor | |
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Investment Managers | Analyst-Equity | |
Three Arch Partners
![]() Three Arch Partners Investment ManagersFinance Three Arch Partners (TAP) is a venture capital firm founded in 1993 by Thomas Fogarty and Wilfred Jaeger. The firm is headquartered in San Mateo, California. | Investment Managers | Comptroller/Controller/Auditor | |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Pharmaceuticals: Major | Director/Board Member | |
Exo Therapeutics, Inc.
![]() Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
MOMA Therapeutics, Inc.
![]() MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cedilla Therapeutics, Inc.
![]() Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 48 |
Vereinigtes Königreich | 3 |
Kanada | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 5 |
Technology Services | 2 |
Operativ
Director/Board Member | 61 |
Corporate Officer/Principal | 22 |
Independent Dir/Board Member | 19 |
Chairman | 11 |
Consultant / Advisor | 8 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Walter Moos | 30 |
Peter Svennilson | 25 |
Thilo Schroeder | 18 |
John Josey | 13 |
Matthew Jacobson | 12 |
David Spellmeyer | 11 |
James Evangelista | 10 |
David J. Earp | 9 |
Steve Kelsey | 9 |
- Börse
- Insiders
- Daniel Veber
- Unternehmensverbindungen